Germany is the leading medtech market in Europe, with a 22% market share. While funding for high-cost innovative medtech in Germany has evolved in recent years, there are still many challenges in securing reimbursement even as demand for these technologies surges. In an analysis published in Med Device Online, we explored how medtech companies should approach the reimbursement pathway for these devices when seeking to enter the German market.
Dr. Annabelle Fowler featured in ERE spotlight series
The feature highlights Dr. Fowler’s path to becoming an expert witness, her approach to solving complex problems, and what she enjoys most about her work....

